DECISIONS MADE BY HONKARAKENNE OYJ’S ANNUAL GENERAL

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DECISIONS MADE BY HONKARAKENNE OYJ’S ANNUAL GENERAL MEETING

HONKARAKENNE OYJ   STOCK EXCHANGE RELEASE 4 APRIL 2014 AT 4:00 P.M.

DECISIONS MADE BY HONKARAKENNE OYJ’S ANNUAL GENERAL MEETING

Honkarakenne Oyj’s Annual General Meeting held on Friday 4 April 2014 in the company headquarters at Tuusula adopted the consolidated and parent company financial statements and granted discharge from liability for 2013 to the members of the Board of Directors and the President and CEO.

Dividends

The Annual General Meeting decided that no dividends be paid for the financial year ending on 31 December 2013.

Members of the Board of Directors and remunerations

Five members were elected to the Board of Directors: Hannu Krook, Teijo Pankko, Anita Saarelainen, Mauri Saarelainen and Arto Tiitinen.

The Annual General Meeting decided to set the remuneration of the members of the Board of Directors at EUR 1,500 per month, the remuneration of the chairman of the board at EUR 4,000 and the remuneration of deputy chairman at EUR 2,000. Should the Board of Directors appoint committees from among its number, the committee members will be paid EUR 500 for each committee meeting. Furthermore, the members’ travel and accommodation costs shall be reimbursed against an invoice.

Auditors

PricewaterhouseCoopers Oy, member of the Finnish Institute of Authorised Public Accountants, was re-appointed as auditor of the company, with Maria Grönroos, APA, as chief auditor. The auditing can be remunerated in accordance with a reasonable invoice.

Authorising the board of directors to decide on the repurchase of the company’s own shares

The Annual General Meeting authorised the Board of Directors to decide on the purchase of no more than 400,000 of the company’s own B shares using funds from the company’s unrestricted shareholders’ equity. The Board of Directors shall decide on the procedure of the share purchase. The company’s own shares may be acquired in a proportion disapplying the pre-emptive rights of the existing shareholders. The authorisation also covers the acquisition of shares in the public trading of NASDAQ OMX Helsinki Oy in accordance with the rules and regulations of OMX Helsinki and Euroclear Finland Oy or by means of a repurchase offer made to the shareholders. Shares may be acquired for the purpose of developing the capital structure of the company, for the financing or implementation of acquisitions or other similar arrangements, for the implementation of the company’s share-based incentive schemes or for other transfers or maculation. The share acquisition shall be based on the share’s market price in public trading, with the minimum price of the share concerned corresponding to the lowest market price quoted for the share in public trading and the maximum price correspondingly being the highest market price quoted in public trading, while the authorisation remains valid. The authorisation also covers the option of taking as pledge the company’s own B shares. The Board of Directors shall decide on all other issues pertaining to the acquisition of its own shares. The authorisation remains in force until 25 March 2015.

Authorising the board of directors to decide on the issue of shares as well as the issue of options and other special rights entitling to shares

The Annual General Meeting authorised the Board of Directors to decide on rights issue or bonus issue and on the granting of special rights entitling to shares in one or more instalments on the following terms and conditions in Chapter 10, section 1 of the Companies Act:

- Under the authorisation, the Board of Directors may issue a maximum of 400,000 new shares and/or transfer old B shares held by the company inclusive of any shares that may be issued.

- The issue may also be made to the company itself, within the legal framework.

- The authorisation entitles the company to depart, within legal provisions, from the shareholders’ priority right to subscribe for new shares (directed issue).

- The authorisation may be used to execute acquisitions or put in place other arrangements within the scope of the company’s business or to finance investment, improve the company’s capital structure, assist in implementing the company’s incentive scheme or for other purposes designated by the Board of Directors.

- The authorisation includes the right to decide on the manner in which the subscription price is recognised in the company’s balance sheet. Apart from cash, other property (property given as subscription in kind) may be used to pay the subscription price, either in full or in part. Furthermore, claims held by the subscriber may be used to set off the subscription price. The Board of Directors is entitled to decide on any other matters arising from the share issue or relating to the special rights giving entitlement to shares.

- The authorisation remains in force until 25 March 2015.

HONKARAKENNE OYJ

Mikko Kilpeläinen

President and CEO

The next interim report for January – March 2014 will be published on Thursday 8 May 2014.

Further information:

President and CEO Mikko Kilpeläinen, tel +358 50 542 5884, mikko.kilpelainen@honka.com

DISTRIBUTION

NASDAQ OMX Helsinki Oy

Key media

Financial Supervisory Authority

www.honka.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 235

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 347

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 276

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 183

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Aurora Innovation Faces Legal Heat Amid Delays

Updated Category News Views 238

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 522

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 271

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 451

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 202

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 104

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading

Top 5 Most Recently Viewed Articles

Canadian Stocks Surge: Understanding Market Dynamics and Trends

Updated Category News Views 178

Canadian Stocks See Notable Gains The Canadian stock market has shown encouraging signs of growth lately, with various sectors playing a part in this upward movement. The S&P/TSX Composite Index achieved a remarkable increase of 0.57%, marking a significant point in its trading history. Key Sectors Driving Market Growth The rise in stock prices can largely be credited to...

Continue Reading
Bookmark Medical Enters Michigan Via Village Medical Buy

Updated Category News Views 38

Stepping into Michigan It might not be a Wall Street headliner, but Bookmark Medical's move into Michigan sure says a lot about their growth ambitions. On August 3, 2026, the Nashville-based healthcare group wrapped up acquiring Village Medical Michigan. This is Bookmark's maiden voyage into the Great Lake State, where it's taken over the reins of seven primary care...

Continue Reading
Astrotech Corporation Reports Impressive Year-End Results

Updated Category News Views 134

Astrotech Corporation Reports Strong Fiscal Performance Recently, Astrotech Corporation (NASDAQ: ASTC) announced its financial results for the fiscal year that ended on June 30. The report highlights notable advancements from its subsidiary, 1st Detect, and how these developments are contributing to overall revenue and growth potential. Key Financial Highlights The...

Continue Reading
Neptune Flood Research Highlights Path to Private Insurance Transition

Updated Category News Views 165

Neptune Flood Research Report Offers Insights on NFIP Transition Recent research indicates that private flood insurers may be capable of taking on 95% of policies from the NFIP, helping to mitigate federal financial exposure. Neptune Flood Research Group has published a comprehensive report analyzing the U.S. flood insurance market. The study emphasizes the challenges...

Continue Reading
Valerio Therapeutics Shifts Focus to Early-Stage Drug Development

Updated Category News Views 131

Valerio Therapeutics Announces Strategic Refocus Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO) has made a pivotal announcement regarding its strategic business direction. The company has decided to halt all clinical trials, including the ongoing VIO-01 trial. This decision comes in response to significant financing challenges impacting the organization. While...

Continue Reading